JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 36 No. 2 211-216
© 1995 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Braams, J. W.
Right arrow Articles by Vermey, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Braams, J. W.
Right arrow Articles by Vermey, A.

Detection of Lymph Node Metastases of Squamous-Cell Cancer of the Head and Neck with FDG-PET and MRI

Jan W. Braams, Jan Pruim, Nicole J.M. Freling, Peter G.J. Nikkels, Jan L.N. Roodenburg, Geert Boering, Willem Vaalburg and Albert Vermey

Department of Oral and Maxillofacial Surgery, National Research PET Center
Departments of Diagnostic Radiology, Pathology and Surgical Oncology, University Hospital Groningen, Oostersingel, Groningen, The Netherlands

Correspondence: For correspondence or reprints contact: J.W. Braams, Department of Oral and Maxillofacial Surgery, University Hospital Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.

ABSTRACT

The uptake of 2-deoxy-2-[18F]fluoro-D-glucose (FDG) in neck lymph nodes of twelve patients with a squamous-cell carcinoma of the oral cavity was studied with PET in order to detect and locate lymphogenic metastases. Methods: The results of FDG-PET imaging were compared with clinical, MRI and histopathologic findings. Standardized uptake values (SUV) were also calculated. Results: A sensitivity of 91% and a specificity of 88% were calculated for FDG-PET. In contrast, a sensitivity of 36% and a specificity of 94% were calculated for MRI. Calculated SUVs for reactive lymph nodes, metastatic lymph nodes and the primary tumor were undifferentiated. Conclusion: Using FDG-PET, lymph node metastases of squamous-cell carcinomas of the oral cavity can be visualized with a high sensitivity and specificity. FDG-PET can be an improvement in the evaluation of the neck.

Key Words: PET • fluorodeoxyglucose • MRI • head and neck metastases




This article has been cited by other articles:


Home page
Br. J. Radiol.Home page
Y-H CHEN, J J-M JIAN, K-Y CHAN, S Y TSAI, S H CHENG, K-C L YEN, and J C-H CHENG
Definitive chemoirradiation for resectable head and neck cancer: treatment outcome and prognostic significance of MRI findings
Br. J. Radiol., June 1, 2008; 81(966): 490 - 498.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
P. A. Kyzas, E. Evangelou, D. Denaxa-Kyza, and J. P. A. Ioannidis
18F-Fluorodeoxyglucose Positron Emission Tomography to Evaluate Cervical Node Metastases in Patients With Head and Neck Squamous Cell Carcinoma: A Meta-analysis
J Natl Cancer Inst, May 21, 2008; 100(10): 712 - 720.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
A D KING, B B MA, Y Y YAU, B ZEE, S F LEUNG, J K T WONG, M K M KAM, A T AHUJA, and A T C CHAN
The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis
Br. J. Radiol., April 1, 2008; 81(964): 291 - 298.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S.-H. Ng, T.-C. Yen, J. T.-C. Chang, S.-C. Chan, S.-F. Ko, H.-M. Wang, L.-Y. Lee, C.-J. Kang, A. M.-C. Wong, and C.-T. Liao
Prospective Study of [18F]Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography and Magnetic Resonance Imaging in Oral Cavity Squamous Cell Carcinoma With Palpably Negative Neck
J. Clin. Oncol., September 20, 2006; 24(27): 4371 - 4376.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
S.-H. Ng, T.-C. Yen, C.-T. Liao, J. T.-C. Chang, S.-C. Chan, S.-F. Ko, H.-M. Wang, and H.-F. Wong
18F-FDG PET and CT/MRI in Oral Cavity Squamous Cell Carcinoma: A Prospective Study of 124 Patients with Histologic Correlation
J. Nucl. Med., July 1, 2005; 46(7): 1136 - 1143.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
F. Dammann, M. Horger, M. Mueller-Berg, H. Schlemmer, C. Claussen, J. Hoffman, S. Eschmann, and R. Bares
Rational Diagnosis of Squamous Cell Carcinoma of the Head and Neck Region: Comparative Evaluation of CT, MRI, and 18FDG PET
Am. J. Roentgenol., April 1, 2005; 184(4): 1326 - 1331.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
N. Mozzillo, F. Chiesa, C. Caraco, G. Botti, S. Lastoria, F. Longo, and F. Ionna
Therapeutic Implications of Sentinel Lymph Node Biopsy in the Staging of Oral Cancer
Ann. Surg. Oncol., March 1, 2004; 11(3_suppl): 263S - 266S.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
D. L. Schwartz, J. Rajendran, B. Yueh, M. Coltrera, Y. Anzai, K. Krohn, and J. Eary
Staging of Head and Neck Squamous Cell Cancer With Extended-Field FDG-PET
Arch Otolaryngol Head Neck Surg, November 1, 2003; 129(11): 1173 - 1178.
[Abstract] [Full Text] [PDF]


Home page
Dentomaxillofac RadiolHome page
E. To, W. Tsang, J Cheng, E Lai, P Pang, A. Ahuja, and M Ying
Is neck ultrasound necessary for early stage oral tongue carcinoma with clinically N0 neck?
Dentomaxillofac. Radiol., May 1, 2003; 32(3): 156 - 159.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
Y. Kitagawa, S. Nishizawa, K. Sano, T. Ogasawara, M. Nakamura, N. Sadato, M. Yoshida, and Y. Yonekura
Prospective Comparison of 18F-FDG PET with Conventional Imaging Modalities (MRI, CT, and 67Ga Scintigraphy) in Assessment of Combined Intraarterial Chemotherapy and Radiotherapy for Head and Neck Carcinoma
J. Nucl. Med., February 1, 2003; 44(2): 198 - 206.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
H.-J. Jeong, J.-K. Chung, Y. K. Kim, C. Y. Kim, D. G. Kim, J. M. Jeong, D. S. Lee, H. W. Jung, and M. C. Lee
Usefulness of Whole-Body 18F-FDG PET in Patients with Suspected Metastatic Brain Tumors
J. Nucl. Med., November 1, 2002; 43(11): 1432 - 1437.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
A. D. Williams, C. Cousins, W. P. Soutter, M. Mubashar, A. M. Peters, R. Dina, F. Fuchsel, G. A. McIndoe, and N. M. deSouza
Detection of Pelvic Lymph Node Metastases in Gynecologic Malignancy: A Comparison of CT, MR Imaging, and Positron Emission Tomography
Am. J. Roentgenol., August 1, 2001; 177(2): 343 - 348.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
S. S. Gambhir, J. Czernin, J. Schwimmer, D. H. S. Silverman, R. E. Coleman, and M. E. Phelps
A Tabulated Summary of the FDG PET Literature
J. Nucl. Med., May 1, 2001; 42(90050): 1S - 93.
[Full Text] [PDF]


Home page
JNMHome page
E. Sutinen, S. Jyrkkio, M. Varpula, P. Lindholm, T. Gronroos, P. Lehikoinen, M. Teras, and H. Minn
Nodal Staging of Lymphoma with Whole-Body PET: Comparison of [11C]Methionine and FDG
J. Nucl. Med., December 1, 2000; 41(12): 1980 - 1988.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
R. J. Kau, C. Alexiou, C. Laubenbacher, M. Werner, M. Schwaiger, and W. Arnold
Lymph Node Detection of Head and Neck Squamous Cell Carcinomas by Positron Emission Tomography With Fluorodeoxyglucose F 18 in a Routine Clinical Setting
Arch Otolaryngol Head Neck Surg, December 1, 1999; 125(12): 1322 - 1328.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1995 by the Society of Nuclear Medicine.